News
-
-
-
COMMUNIQUÉ DE PRESSE
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
Evotec partners with Inserm, Lille University Hospital & Inserm Transfert to identify therapeutic targets in obesity & metabolic diseases. Collaboration to leverage PanOmics technologies -
-
-
COMMUNIQUÉ DE PRESSE
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
Evotec SE extends strategic drug discovery collaboration with CHDI Foundation in Huntington's disease, emphasizing commitment to developing new therapies and improving patients' lives -
-
-
COMMUNIQUÉ DE PRESSE
Evotec reports Q1 2024 results and provides corporate update
Evotec SE reports Q1 2024 financial results and corporate update, outlines growth in Just - Evotec Biologics and challenges in transactional business. New CEO and CPO appointments. Group revenues expected to grow double-digit in FY 2024 -
